A 2002 poll among American doctors was updated in 2007 to determine how physicians’ feelings about national health insurance (NHI) may have changed in the 5 year period.
In 2002, 49% favored a national plan. In 2007, 59% supported such a plan.
The chart on the left details findings by physician specialty. Not surprisingly, more generalist doctors favor a national health plan compared to specialists, although there is still support for national insurance by a plurality of specialists and the support has grown over five years.
Psychiatrists, long supporting mental health parity in American health financing, are at the vanguard of NHI support. Pediatricians, emergency doctors, and internists make up the over-50% crowd in support of NHI.
The emergency physicians’ support for NHI has dramatically grown since 2002, probably due to the fact that these clinicians are at the forefront of caring for the uninsured. They see firsthand that uninsurance and underinsurance often drives consumers to the ER. A recent study at Harvard published in Health Affairs found that overcrowding in emergency rooms has led to those with the most urgent conditions being at-risk.
Health Populi’s Hot Points: Physician support of national health insurance is nothing new. For over twenty years, Physicians for a National Health Program (PNHP) has focused its mission on achieving a single-payer system in the U.S. Today, PNHP has more than 15,000 members throughout the U.S.
That more physicians are joining the ranks of people in search of universal coverage moves the concept way past the tipping point in the U.S.






Thank you
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.